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ABSTRACT 
 
 This study evaluated a family exhibiting the phenotype of non-syndromic tooth 
agenesis through whole exome sequencing to potentially identify pathogenic variants.  Four 
family members, three with tooth agenesis and one without, were enrolled as on-site subjects 
for whole exome sequencing analysis using genomic DNA isolated from their blood samples.  
Variants found to segregate with the tooth agenesis phenotype were evaluated further.  An 
additional three family members, all with tooth agenesis, were enrolled as off-site subjects.  
DNA isolated from these subjects were evaluated by means of polymerase chain reaction and 
restriction enzyme testing to confirm or exclude the potential candidate variants based on 
their segregation in the off-site subjects.   
 Twenty-six variants were found to segregate with the tooth agenesis phenotype 
among the four on-site subjects.  Potentially pathogenic mutants were identified through data 
filtering techniques such as DOMINO, CADD, and pLI.  Of the twenty-six variants, seven 
heterozygous variants in novel candidate genes for tooth agenesis were identified: AHCYL1, 
WNT5B, HOXB2, VMP1, JUP, RNF43, and TP1.  Only two variants created or destroyed a 
restriction enzyme site and thus, were able to be evaluated in the off-site subjects utilizing 
PCR/restriction enzyme testing, resulting in the elimination of JUP as a candidate variant. 
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 The six remaining novel candidate genes were then assessed through a literature 
review.  It was determined that WNT5B, HOXB2, and RNF43 may have a role in early 
odontogenesis by potentially altering the key dental epithelium/mesenchyme interactions.  
RNF43 emerged as the most likely causal variant due to the significance of the altered 
interaction site between RNF43’s binding groove and RSPO1’s β-hairpin protrusion, 
ultimately leading to dysregulation of the Wnt signaling pathway.  Also, it was revealed that 
three families, in a larger genetic study evaluating tooth agenesis, had mutations in RNF43.  
One of which, had an identical change at the 97th position from an aspartic acid to an 
asparagine, which further strengthened our belief in RNF43 being the causal variant.  
Analysis of the un-recruited family members and selective sequencing of the off-site subjects 
for the five candidate variants that did not alter restriction enzyme sites could help to rule out 
oligogenic inheritance.   
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CHAPTER 1 
INTRODUCTION 
Teeth play a pivotal role in many areas of an individual’s well-being: chewing, 
speech, maxillary and mandibular bone loading to name a few.  It is no surprise that one of 
the main goals of dentistry has always been to maintain and hopefully improve the health of 
an individual’s dentition to prevent any future loss.  Yet, some individuals start with a 
disadvantage making the maintenance of dental health even more of a priority.   
Overview of Tooth Agenesis 
The most common human developmental craniofacial anomaly is dental agenesis (De 
Coster et al. 2009).  Tooth agenesis is often classified as either hypodontia, congenitally 
missing between one to five teeth (excluding third molars) or oligodontia, congenitally 
missing six or more teeth (excluding third molars).  The most severe and rarest form of tooth 
agenesis is anodontia, or a complete absence of tooth formation (Tallon-Walton et al. 2014).  
Anodontia is rarely sporadic and normally associated with syndromes such as more severe 
forms of ectodermal dysplasias, Kabuki syndrome, and Fried syndrome (Fauzi et al. 2018). 
Overall, hypodontia, excluding third molars, has been seen at a prevalence of 6.4%.  
The highest prevalence of hypodontia occurs in Africa (13.4%) and progressively decreases 
in Europe (7%), Asia (6.3%), Australia (6.3%), North America (5%), and Latin America plus 
Caribbean (4.4%) (Khalaf et al. 2014).  The prevalence of third molar agenesis had a wide 
range from 5.32% to 56.0% depending on the subgroup but when taken as a whole, the 
worldwide prevalence sits at 22.63% (Carter and Worthington 2015).  The primary dentition 
is rarely affected by congenitally missing teeth, in the range of 0.1% and 2.4%, but when a 
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primary tooth is missing, the succedaneous permanent tooth is often missing as well 
(Rakhshan 2015). 
Congenitally missing permanent teeth may present as an isolated, non-syndromic trait 
or as a condition of an associated syndrome (Mostowska et al. 2013).  Over 60 different 
syndromic conditions are listed in the Online Mendelian Inheritance in Man (OMIM) 
database that have been found to be associated with hypodontia.   Non-syndromic tooth 
agenesis is the much more likely form of the two and the number of teeth affected can vary 
(Cobourne 2007).  The most commonly missing tooth, excluding third molars, was the 
mandibular second premolar (3%) followed by the maxillary lateral incisor (1.7%), the 
maxillary second premolar (1.5%), and finally the mandibular central incisor (0.3%) (Polder 
et al. 2004).  The absence of canines and first and second molars are exceptionally rare and 
usually only found in the more severe forms of oligodontia with syndromic association 
(Symons et al. 1993). 
Tooth number is not the only anomaly seen in individuals affected by non-syndromic 
tooth agenesis.  Teeth that are present in these individuals can often have a conical crown 
shape, reduced crown to root ratio, molar taurodontism, enamel hypoplasia, transposition and 
canine misposition to name a few (Baccetti 1998; Peck et al. 2002).  
Impact of Hypodontia 
A recent study conducted to evaluate the oral health-related quality of life of children 
with hypodontia found that tooth agenesis has a significant psychosocial impact on the 
children regardless of gender, socioeconomic status or ethnic group.  There was a clear 
association with hypodontia and children experiencing functional limitations as well as 
having an impact on their social and emotional well-being (Kotecha et al. 2013).  In a study 
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of 451 individuals, dissatisfaction with appearance was a major concern associated with 
congenitally missing teeth (Hobkirk et al. 1994).  The psychosocial impact is a continuous 
theme in the literature and is expected as increased spacing is common in affected individuals 
and as the maxillary lateral incisor is the second most common missing tooth (excluding third 
molars), the spacing is often visible.    
The impact of hypodontia is not limited to the psychosocial though.  A group of 4,204 
randomly selected patients at a University dental clinic were examined to determine the 
prevalence of temporomandibular symptoms and parafunctional habits and their associations 
with gender, age, and missing teeth.  The researchers detected a significant association 
between the number of missing teeth and symptoms such as clenching/grinding and difficulty 
chewing (Chatzopoulos et al. 2017).  
Etiology of Tooth Agenesis 
Human tooth development is a complex process of synergistic and antagonistic 
interactions between the odontogenic epithelium and mesenchyme derived from cranial 
neural crest cells that migrated into the regions of the jaw where eventual tooth formation 
will occur (Tucker and Sharpe 2004).  These processes are directed by the variable 
expression of specific transcription factors such as Sonic hedgehog (Shh), Wingless (Wnt), 
bone morphogenic proteins (BMP), and fibroblast growth factors (FGF) (Fauzi et al. 2018).  
In fact, over 300 genes have been listed as being expressed in various stages of 
odontogenesis (Al-Ani et al. 2017).   
Classically, odontogenesis has been divided into bud, cap, and bell stages (Fauzi et al. 
2018).  Initiation of tooth development begins with the formation of a thickening of the 
odontogenic epithelium, or the dental lamina.  After this formation, the tooth-forming 
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potential, which initially resides with the epithelium, shifts to the mesenchyme eventually 
resulting in the formation of the tooth bud as the dental lamina grows into the underlying 
mesenchyme.  Following this ingrowth, the tooth-forming potential once again returns to the 
epithelium in the form of the enamel knot that directs further tooth formative processes 
(Kapadia et al. 2007).  MSX1 and PAX9 are two well studied transcription factors that 
appear to be key regulators in these early odontogenesis phases (Jernvall and Thesleff 2000).   
PAX9 is a member of the paired box (PAX) family of transcription genes.  The gene 
is located on the long arm of chromosome 14 at cytogenic location 14q13.3 (Bonczek et al. 
2017; Fauzi et al. 2018).  Evidence suggests that PAX9 helps to establish the moment and 
location of odontogenesis (Thomas and Sharpe 1998).  PAX9 plays a crucial role in the 
regulation of epithelial-mesenchymal interactions involving signaling of BMP4 and SHH 
(Yin and Bian 2015).  
Utilizing the mouse embryonic model, PAX9 was found to be an early marker for 
tooth development, appearing at mouse embryonic day 10 (E10) prior to the expression of 
other tooth signaling genes. The high level of PAX9 expression is then maintained 
throughout initiation, bud, and cap stages, eventually being down regulated at the bell stage 
during E16.  This early mesenchymal expression of PAX9 is induced by FGF8 from the 
dental epithelium and restricted to prospective tooth development sites by BMP4, which acts 
as an antagonistic signal (Peters et al. 1998a). PAX9 deficient mice were developed to 
evaluate its effect on mammalian development and organogenesis.  In the homozygous Pax9-
mutant mice, all teeth are absent as tooth development was arrested at the bud stage.  The 
investigators found that PAX9 is required for the inductive capacity of the tooth mesenchyme 
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to be established since PAX9 is necessary for the mesenchyme to express BMP4, MSX1, and 
LEF1 (Peters et al. 1998b). 
PAX9 variants have consistently been discovered through genetic testing of families 
with non-syndromic tooth agenesis.  A missense mutation, P20L in PAX9, was described in a 
single Japanese family involving three patients in two generations.  The investigators 
demonstrated that the mutation eliminated the majority of PAX9’s transactivation activity and 
its DNA binding activity (Murakami and Yasuhira 2017).  In a Finnish family, a nonsense 
mutation creates a stop codon at lysine 114 in the PAX9 gene and results in a truncated PAX9 
protein.  The affected family members were missing all second and third molars as well as 
most of their first molars as a result (Nieminen et al. 2001).  In a recent review of PAX9 
mutations associated with non-syndromic tooth agenesis, 22 mutations had been found and 
compiled from the literature (Fauzi et al. 2018). 
The other key player in early odontogenesis is muscle segment homeobox 1, or 
MSX1, which is also located on the chromosome 4.  MSX1 functions in numerous cell types 
acting to regulate differentiation, proliferation, and angiogenesis.  During craniofacial 
development, MSX1 is a direct target downstream in the WNT/β-catenin signaling pathway 
and acts as a regulator of the pathway’s expression and activity (Tallon-Walton et al. 2014; 
Yin and Bian 2015). 
PAX9 and MSX1 have been shown through both chemical assays and transgenic 
mice to act synergistically leading to the activation of BMP4 in the dental mesenchyme 
(Peters et al. 1998a; Ogawa et al. 2006).  BMP4 is critical during tooth morphogenesis for the 
progression of the bud stage to the cap stage and is also a key factor in the signaling pathway 
involving PAX9 and MSX1 (Mostowska et al. 2012). 
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 The list of other genes found to be associated with non-syndromic tooth agenesis 
continues to grow such as EDA/EDAR (Shen et al. 2016), AXIN2 (Bergendal et al. 2011; Liu 
et al. 2015), LTBP3 (Dugan et al. 2015), WNT10A (Plaisancie et al. 2013; Arzoo et al. 2014), 
and WNT10B (Kantaputra et al. 2018).  Recently, a study utilizing whole-exome sequencing 
identified a number of novel candidate genes such as COL17A1, LAMA3, LRP6, and DKK1 
(Dinckan et al. 2018).  
Identification of Causal Genes 
Prior to the era of the human genome project and whole genome sequencing, the 
identification of causal genes was a complex, costly, and time-consuming process.  Often, a 
family linkage approach was utilized to progressively localize and eventually identify a 
candidate gene and/or mutation.  This approach requires a careful ascertainment of the 
affected kindred and subsequent linkage analysis, which utilizes the tendency for similarly 
located loci on a single chromosome to be inherited together (Teare and Santibanez Koref 
2014). Alternatively, loci that are not near to one another have a higher likelihood of being 
separated by crossover events during Meiosis I and as a result are not inherited together 
(Nussbaum et al. 2007).  Thus, loci (or genetic markers) closer to the disease causing trait 
gene are more likely to be inherited with the trait in affected members of a family. 
By using DNA markers with known genetic locations, the percentage of 
recombination events, or the recombination frequency, can be identified for each genetic 
marker in combination with the candidate gene in affected offspring of the kindred.  
Recombination frequencies allows for the distance between the two loci to be measured in 
centi-Morgans (cM).  A centi-Morgan is the genetic length within which a recombination 
event occurs one percent of the time on average (i.e. once per 100 meiosis).  This estimated 
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distance relies on having an adequate number of offspring to be confident in the calculated 
recombination frequency, which underlines the importance of the ascertainment of the 
kindred (Nussbaum et al. 2007). 
 Even with a high confidence in the recombination frequency though, identifying the 
exact location of the candidate gene was not possible with linkage analysis alone.  Targeted 
sequencing would be required of the region to which the gene was localized.  This was often 
costly, especially before reliable human reference sequences and detailed genetic/physical 
maps  were made more readily available, as it required identifying yeast or bacterial clones 
carrying sequences of the region of interest and their subsequent sequencing (Teare and 
Santibanez Koref 2014). 
 A much more efficient means to identify a candidate gene, albeit much more costly, 
would be through DNA sequencing.  From the beginning in the early 1970s, advancements 
have been a relatively slow but gradual climb to the current sequencing techniques.  Early 
attempts were cumbersome with one base being identified per month, to a few hundred in an 
afternoon, and eventually to a thousand bases per day utilizing the automated Sanger 
sequencing technique developed by the late 1980s.  Even with the development of bacterial 
artificial chromosomes being used in combination with automated Sanger sequencing, the 
system was not efficient enough to sequence the whole human genome at a reasonable cost.  
Efficiency and scale had to be improved at each step (Shendure et al. 2017). 
 Parallel improvements in computing helped aid the advancement of high throughput 
DNA sequencing as it replaced human decision making when interpreting and assembling the 
sequence data and allowed for automated production lines that could generate up to 10 
million bases per day.  These advancements resulted in the first draft of the human genome 
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from the Human Genome Project in 2001.  Within a decade of the initial draft of the human 
genome, an alternative to electrophoretic sequencing called “massively parallel” or “next-
generation” sequencing (NGS) would soon replace traditional Sanger sequencing. Instead of 
one tube per reaction, a whole library of DNA templates could be run using a single reagent 
volume.  In vitro amplification created the necessary copies of each template to be sequenced 
rather than using bacterial cloning (Shendure et al. 2017).  Steady improvements in NGS and 
computing has continued to increase the efficiency and speed at which sequencing can be 
performed and ultimately has led to a substantial decrease in cost.  
 Through the work of the Human Genome Project and other similar projects, the 
approximate overall size of the human genome has been found to be 3.08Gb, or 3.08 billion 
base pairs, but repeating sequences account for over half of these base pairs (Platzer 2006).  
Due to this realization, whole exome sequencing was developed as an accelerated means of 
identifying pertinent information because it is the selective sequencing of the sections of the 
genome that encode proteins.  These sections typically only account for around 1-2% of the 
genome (Shendure et al. 2017).  This development has allowed researchers to scan large 
numbers of genes at a much cheaper cost as compared to whole genome sequencing, since 
only a small amount (less than 5%) of candidate genes implicated in Mendelian diseases have 
been located in regulatory regions (Teare and Santibanez Koref 2014).  
Problem Statement 
A family exhibiting the phenotype of non-syndromic tooth agenesis has been 
identified through the University of Missouri – Kansas City Advanced Orthodontic Clinic.  
Currently, there are roughly 15 genes known to be associated with non-syndromic tooth 
agenesis, despite the fact that over 300 genes have been identified as involved in the various 
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stages of odontogenesis.  The main purpose of this study was to ascertain a family with tooth 
agenesis, determine the pattern of inheritance and identify the causative variant underlying 
the non-syndromic tooth agenesis phenotype utilizing exome sequencing.  Once the 
candidate variant is identified, it will be compared against known genes causal for tooth 
agenesis in other families identified in the current literature to determine if it is a novel 
gene/mutation. Through informatics approaches and literature review, we will determine a 
potential function associated with this gene in tooth development and the consequences of 
the mutation. 
Hypothesis 
1. There will be a common single gene mutation found only in affected family members. 
2. The mutated gene will play a role in the early stages of tooth formation. 
 
10 
 
CHAPTER 2 
MATERIALS AND METHODS 
IRB Approval 
 This study was approved by the Institutional Review Board at the University of 
Missouri – Kansas City, Kansas City, Missouri (#2015303) (Appendix 1). 
Recruitment 
 A Caucasian family was identified with an autosomal dominant form of non-
syndromic tooth agenesis through the Advanced Orthodontic clinic at the University of 
Missouri – Kansas City School of Dentistry (fig. 1).  Four family members, three affected 
and one unaffected, were recruited for whole exome sequencing.  All other available family 
members willing to participate were recruited for PCR - restriction enzyme testing to verify 
the presence of the candidate variant(s).  Informed consent was obtained prior to any research 
activities.  Draft of pedigree was created with input from the proband (fig.1).   
 
 
Figure 1.  Pedigree of the family affected by non-syndromic tooth agenesis. 
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Sample Collection and DNA Extraction 
Five milliliters (mL) of blood was collected in EDTA (ethylenediaminetetraacetic 
acid) blood collection tubes from three family members at the University of Missouri – 
Kansas City School of Dentistry by a qualified nurse.  When the subjects arrived, they 
reported to the Advanced Orthodontic Clinic.  Prior to performing an intraoral examination 
and collecting the blood sample, an on-site informed consent form, HIPAA form, and study 
questionnaire were presented personally in a private consultation room.  All forms were then 
signed and dated.  The informed consent form (Appendix 2) details the primary goals of the 
study, risks/benefits, and what is required during their participation.  A HIPAA form 
(Appendix 4) was presented to authorize the release of the subject’s recent radiographs, 
dental records, and medical history.  Finally, a questionnaire (Appendix 5) was administered 
to evaluate the subject’s presentation of the phenotype in question. 
Genomic DNA was extracted from the whole blood samples utilizing a DNA 
extraction kit1 according to the manufacturer’s instructions. In brief, 1-2 ml of whole blood 
(PBS is added as needed to reach 2 ml) was mixed with 200μl of QIAGEN protease to lyse 
the cells.  Buffer AL (2.4 ml) was added, inverted 15 times, and vigorously mixed for 1 
minute.  The sample was incubated at 70 degrees for 10 minutes to allow for maximum DNA 
yield.  2 ml of ethanol (99.5%) was added to the sample, inverted 10 times, and followed by 
vigorous shaking.  The sample was centrifuged for 3 minutes at 3,000 rpm.  The filtrate was 
discarded.  2 ml of Buffer AW1 was added and the tube centrifuged at 4000 rpm for 1 
minute.  2 ml of Buffer AW2 was added and the tube centrifuged at 4000 rpm for 15 minutes.  
                                                 
1 QIAamp Blood Midi Kit, Qiagen, 19300 Germantown Road, Germantown, MD 20874 
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300 μl of room temperature (15-25 degrees Celsius) Buffer AE was added, incubated at room 
temperature for 5 minutes, and centrifuged at 4000 rpm for 2 minutes.  To increase the 
concentration, the eluate (~300 μl) was reloaded onto the membrane of the QIAamp midi 
columns and again incubated at room temperature for 5 minutes and centrifuged at 4000 rpm 
for 2 minutes.  This process was repeated until DNA was isolated from all of the subject’s 5 
ml blood sample. 
Off-site subjects, those unable to come to the University of Missouri – Kansas City 
School of Dentistry for a blood draw, had a saliva collection kit2 sent to them for 
confirmation that they carry the same DNA mutation identified in the “core” family members 
(on-site subjects with a blood draw).  Validation was performed using PCR – restriction 
enzyme studies.  A prepaid package containing the saliva collection kit, an off-site informed 
consent form (Appendix 3), a HIPAA form, and study questionnaire was mailed to each off-
site subject.  Package instructions (Appendix 6) were sent alongside the package prompting 
the subjects to not open the package until they have contacted the principal researcher, who 
will administer the informed consent and provide further details on the other forms included 
and the saliva collection kit.   
In brief, ~2ml of saliva was collected in the supplied tube in the kit.  The tube was 
capped and shipped back to the lab at UMKC. Prior to sample collection, the subject may not 
have any food or drink for 30 minutes.  Genomic DNA was extracted from the received 
saliva sample utilizing a DNA extraction kit3 according to the manufacturer’s instructions.  4 
ml of PBS was added to 1ml of the sample and centrifuged at 1800 x g for 5 minutes.  The 
                                                 
2 Oragene DNA OG-500, DNA Genotek, 3000 – 500 Palladium Drive, Ottawa, Ontario, Canada K2V 1C2 
3 QIAamp DNA Blood Mini Kit, Qiagen, 19300 Germantown Road, Germantown, MD 20874 
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supernatant was removed and the pellet resuspended in 180 μl of PBS.  20 μl of QIAGEN 
Protease and 200 μl of Buffer AL was added and mixed immediately by vortexing for 15 
seconds for efficient lysing to occur.  The sample was incubated for 10 minutes at 56 oC.  200 
μl of ethanol (96-100%) was added and mixed by vortexing the sample.  The sample was 
then placed in a QIAamp Spin Column in a 2 ml collection tube and centrifuged at 6000 x g 
for 1 minute.  The QIAamp Spin Column was transferred to a clean 2 ml collection tube.  500 
μl of Buffer AW1 was added to the Spin Column, centrifuged at 6000 x g for 1 minute, and 
the Spin Column transferred to a clean 2 ml collection tube.  500 μl of Buffer AW2 was 
added to the Spin Column and centrifuged at full speed for 3 minutes.  The Spin Column was 
transferred to a clean 1.5 ml microcentrifuge tube.  The DNA was eluted by adding 150 μl of 
Buffer AE, incubated at room temperature for 1 minute, and centrifuged at 6000 x g for 1 
minute. 
Extracted DNA samples from both blood and saliva was de-identified, coded with a 
unique identifier and kept in a secure electronic database, and archived. 
Next Generation Sequencing (NGS) 
 Whole Exome Sequencing (WES) was performed at the Center for Pediatric Genomic 
Medicine laboratory at Children’s Mercy Hospital utilizing the de-identified DNA samples 
from the four subjects.  WES was prepared using the IDT v1 Exome Panel Kit4. 
Whole Exome Sequencing (WES) 
 
 Sequencing was completed on an Illumina NovaSeq 6000 instrument5 using paired 
end 2 x 150 base pair reads.  Samples was sequenced for a mean coverage of ~80 x (WES).  
                                                 
4 Integrated DNA Technologies, 1710 Commercial Park, Coralville, IA 52241 
5 Illumina, 5200 Illumina Way, San Diego, CA 92122 
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Variant Calling 
 
Base calling was performed and a minimum of 500,000 raw cluster density with 75% 
passing filter and 80% or greater of reads above Q30 were required.  Once these quality 
checks (QC) metrics were satisfied, samples were then processed through an alignment and 
variant detection pipeline using DRAGEN 3.3.7 (Miller et al. 2015).  Post-pipelining QC 
included a minimum of 6 Gb of data obtained once alignment was completed.   
Analysis 
 
Variant annotation and classification was performed using Rapid Understanding of 
Nucleotide variant Effect Software (RUNES v3.4.3-v4.2.4) as previously described 
(Saunders et al. 2012; Soden et al. 2014).  RUNES utilizes American College of Medical 
Genetics (ACMG) recommendations to categorize the variants and assigns each variant a 
minor allele frequency (MAF).  Category 1 variants were reported previously as disease-
causing.  Category 2 variants have not been previously reported as disease-causing but were 
types that are expected to be pathogenic (loss of initiation, disruption of stop codon, 
premature stop codon, frameshifting in/del, disruption of splicing, whole gene deletion).  
Category 3 were variants of unknown significance that may potentially be disease-causing 
(in-frame in/del, non-synonymous substitution, disruption of polypyrimidine tract, overlap 
with 5’ exonic, 5’ flank, or 3’ exonic splice contexts).  Category 4 variants were those 
probably not disease-causing (intronic variants >20 nt from intron/exon boundary, 
synonymous variants unlikely to produce a cryptic splice site, and variants commonly 
observed in unaffected individuals). Category 5 were known to be benign (Miller et al. 
2015). 
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Variants were filtered to a 0.5% minor allele frequency and prioritized by type using 
Variant Integration and Knowledge INterpretation in Genomes (VIKING) software, as 
previously described (Saunders et al. 2012; Soden et al. 2014), and using the ACMG 
guidelines (Richards et al. 2015).  Pathogenic variants, likely pathogenic variants, and 
variants of unknown significance in genes related to the phenotype were prioritized.   
Restriction Enzyme Testing 
 As candidate variant(s) were identified, PCR – restriction enzyme validation studies 
were performed on the non-sequenced (off-site samples) and previously sequenced (on-site 
samples)(as a control) DNA samples from other family members depending on the location 
of the candidate variant and the availability of a restriction enzyme site localized to the area. 
 Utilizing a software called Mutalyzer (v2.0.32) and the variant locations, it was 
determined if a restriction enzyme site was created or destroyed by the mutation (Wildeman 
et al. 2008).  If a restriction enzyme site was available, a PCR primer was designed to flank 
the mutation creating roughly 500-600 bp (base pair) PCR products.  18-23 bp PCR primers 
were designed utilizing a PCR primer tool called Primer3 (Koressaar and Remm 2007; 
Untergasser et al. 2012).  The software NEBcutter was utilized to determine which restriction 
enzyme would be best suited for each gene based on the number of cuts, preferring the least 
amount of cuts made (Vincze et al. 2003).  Both primers and restriction enzymes were then 
purchased from a commercial source6.   
The PCR primers were reconstituted to create 100μM stock by adding the specified 
amount of water to each primer based on the manufacturer’s specification sheet.  A 10μM 
                                                 
6 New England BioLabs, 240 County Road, Ipswich, MA 01938 
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working solution was then created for each primer set by adding 10μl of both forward and 
reverse primers to 80μl of water.  The polymerase chain reactions were completed utilizing 
five repeats of 20μl reaction volumes for each PCR primer for all on-site and off-site DNA 
samples.  The 20μl reaction consisted of 10μl of REDTaq ReadyMix PCR Reaction Mix7 
(DNA polymerase), 5μl of DNA, 1μl of the primer mix, and 4μl of water.  The PCR 
conditions were 1 cycle of 5 min at 94°C, followed by 40 cycles of 30 sec at 94°C, 30 sec at 
55°C, and 30 sec at 72°C, and finishing with 7 min incubation at 72°C utilizing the Applied 
Biosystems 9800 Fast Thermal Cycler8.  PCR repeats of each DNA/primer pair were then 
pooled and stored at -20°C. 
Following the PCR reactions, restriction enzymes specific to the location of the 
candidate variant were used to cleave either the wild-type (non-mutated) gene leaving a non-
cleaved mutated gene or the mutated gene leaving a non-cleaved wild-type gene.  With either 
design, there was a clear distinction in the DNA fragment sizes of the wild-type gene and the 
variant gene PCR products that could be easily resolved by gel electrophoresis.  The 
restriction enzyme digest consisted of 5μl of the PCR product, 10μl of the 10X buffer, 1μl of 
the restriction enzyme, and 34μl of water for a total reaction volume of 50μl.  Each sample 
was then incubated in a 37°C water bath for at least one hour. 
Gel electrophoresis was conducted using 1.2% agarose gel prepared with 0.3g of 
Bullseye Green Choice Agarose9, 25ml of 1X TAE, and 0.25μl of ethidium bromide.  The 
gels were cast in a Thermo Scientific Owl EasyCast B2 Mini Gel Electrophoresis chamber10.  
                                                 
7 Sigma-Aldrich, 3050 Spruce Street, St. Louis, MO 63103 
8 Applied Biosystems, 850 Lincoln Centre Drive, Foster City, CA 94404 
9 Midwest Scientific (MIDSCI), 280 Vance Road, St. Louis, MO 63088 
10 Thermo Fisher Scientific, 168 Third Avenue, Waltham, MA 02451 
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Five microliters of EZ load 100bp Molecular Ruler (#1708352)11 was loaded into the first 
column of the gel.  Columns 2-5 were loaded with 8μl of the on-site subjects’ DNA/RE 
reactions, while columns 6-8 were loaded with 20μl of the off-site subjects’ DNA/RE 
reactions.  The difference in volume used was due to the lower DNA concentrations found in 
the DNA isolate from the off-site subjects’ saliva samples compared to that of the DNA 
isolate from the on-site subjects’ blood samples.  Each gel was run at 80V and 300mA for the 
time required for satisfactory separation, typically one hour.  DNA was visualized and 
photographed using an imaging system12. 
 
Experimental Design and Sample Size 
 This study was performed utilizing whole exome sequencing of four family members 
recruited through the University of Missouri – Kansas City, School of Dentistry (UMKC), 
three of which exhibiting the tooth agenesis phenotype and one that does not.  The sample 
size included seven members out of the thirteen family potential members as three other 
members were recruited as off-site subjects.  
Once the annotated variant files were received from Children’s Mercy Hospital 
following whole exome sequencing, variants were analyzed to identify candidate variants.  
Utilizing the subjects’ phenotypes as the independent variable, we were able to identify 
candidate variants (dependent variable) as there should be variants only found in the 
members of the family demonstrating the tooth agenesis phenotype, while the control family 
members without tooth agenesis should be missing these variants (table 1).  Of these 
                                                 
11 Bio-Rad Laboratories, 1000 Alfred Nobel Drive, Hercules, CA 94547 
12 Azure C400, Azure Biosystems, Inc., 6747 Sierra Court, Suite A-B, Dublin, CA 94568 
18 
 
candidate variants, public allele frequency databases such as the Genome Aggregation 
Database (gnomAD, gnomad.broadinstitute.org) and the Children’s Mercy Hospital Variant 
Warehouse (warehouse.cmh.edu) were used to identify common variants with known 
phenotypes not associated with the tooth agenesis phenotype allowing the removal of these 
variants from consideration.  Once candidate variant(s) were identified, PCR - restriction 
enzyme testing was performed to confirm that the variant(s) were found in the three affected 
off-site subjects.   
TABLE 1 
EXPERIMENTAL DESIGN 
Phenotype 
(Independent variable) 
Exome Sequencing 
Genetic Variants 
(Dependent variable) 
Candidate Variant Evaluation 
(Dependent variable) 
On-site Subjects with 
Tooth Agenesis 
(three subjects) 
Whole exome sequencing 
variant lists 
Identify common genetic variants 
of on-site subjects with tooth 
agenesis 
On-site Subjects without 
Tooth Agenesis (one 
subject) 
Whole exome sequencing 
variant list 
Exclude any common genetic 
variant(s) above that are present 
in on-site subjects without tooth 
agenesis 
Off-site Subjects with 
Tooth Agenesis 
Not sequenced Confirm candidate variant(s) 
found by WES are present in off-
site subjects with tooth agenesis 
through PCR-RE testing 
Off-site Subjects without 
Tooth Agenesis 
Not sequenced Confirm candidate variant(s) 
found by WES are not present in 
off-site subjects without tooth 
agenesis through PCR-RE testing 
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Data Analysis 
Initially, candidate variants were identified by evaluating shared rare variants 
between the affected on-site subjects and not present in the unaffected subject.  Based on the 
phenotypic presentation demonstrated throughout the family, it can be reasonably assumed 
that the variant will be inherited in a dominant fashion.  DOMINO is a tool that uses machine 
learning to assess the likelihood that a gene could cause a dominantly inherited disease 
(Quinodoz et al. 2017).  Genes are broken down into five categories based on their 
probability of being autosomal dominant: “very likely dominant” (0.8-1.0), “likely 
dominant” (0.6-0.8), “either dominant or recessive” (0.4-0.6), “likely recessive” (0.2-0.4), 
and “very likely recessive” (0-0.2).  Variants in genes that fell in the “likely recessive” and 
“very likely recessive” categories were no longer considered as candidate variants.  
 After determining which variants are likely dominant in nature, a CADD score was 
calculated for these remaining variants.  CADD, or Combined Annotation-Dependent 
Depletion, scores are calculated through a machine learning software derived from 
surrounding sequence context, evolutionary constraint, epigenetic measurements, gene model 
annotations and functional predictions.  CADD scores can help determine which variants are 
likely deleterious, or phenotypically influential, mutations.  The scores are on a scale so that 
a variant scored between 0 and 10 is in the bottom 90% of deleterious variants, between 10 
and 20 is in the top 10% and above 20 is in the top 1% (Rentzsch et al. 2019).   
Variants were also evaluated using the Genome Aggregation Database (gnomAD) 
assembled by a worldwide coalition of investigators to gather and harmonize exomic and 
genomic sequencing data.  It was used to attain the predicted loss-of-function (pLoF) variants 
and the probability of LoF intolerance (pLI) for each of our candidate genes.   Nonsense, 
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splice acceptor, and splice donor variants caused by single nucleotide changes are included in 
the pLoF values.  The pLI score refers to the probability that a given gene is haploinsufficient 
and therefore, extremely intolerant of loss-of-function variation.  The closer to one the value 
is, the more LoF intolerant the gene is (Samocha et al. 2014; Lek et al. 2016).  
 Finally, a literature based search was completed to assess the potential function 
and/or consequences of the identified variant(s).  Knowledge gained from the literature could 
help determine if a variant remains a candidate based on similar functions of known variants 
that cause similar tooth agenesis phenotypes. 
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CHAPTER 3 
RESULTS 
Phenotypic Characterization 
 Of the 13 family members invited to participate, a total of seven family members 
accepted and were enrolled into the study.  Four family members, three with tooth agenesis 
(03D, 03G and 03H in fig. 1) and one without (02E in fig. 1), had their blood drawn, DNA 
isolated and had their samples sent to the Center for Pediatric Genomic Medicine laboratory 
at Children’s Mercy Hospital for whole exome sequencing.  The remaining three family 
members (02A, 02B and 03E in fig. 1), all with tooth agenesis, were enrolled as off-site 
subjects and had saliva samples mailed in for DNA isolation and further testing.   
The phenotype varies widely between family members as subject 03E is congenitally 
missing only two permanent teeth (fig. 2) while the most severely affected member (subject 
03H) is missing ten permanent teeth (fig. 3).  There also does not seem to be a consistent 
pattern in which teeth are missing, even between siblings (fig. 3 and 4).  Tooth agenesis was 
confirmed to be in both generations.  None of the subjects examined had an associated 
enamel disorder or any other medical condition that may have had an effect on their 
dentition, which suggests that the tooth agenesis arises from a non-syndromic origin.   
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Figure 2.  Full mouth radiograph series of subject 03E.  Showing two congenitally missing 
teeth: lower left second premolar and lower right third molar.  The subject has also had two 
teeth extracted: both upper third molars. 
 
 
 
Figure 3.  Full mouth radiograph series of subject 03H.  Showing nine congenitally missing 
teeth: upper right second molar, both lower second premolars, both lower central incisors and 
all third molars.   
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Figure 4.  Panoramic radiograph of subject 03G.  Showing nine congenitally missing teeth: 
upper right second premolar, both upper second molars, both lower second premolars and all 
third molars.  
 
 
Figure 5.  Panoramic radiograph of subject 02A.  Showing *five congenitally missing teeth: a 
premolar and all four third molars.  The three remaining premolars have been extracted for 
orthodontic reasons.  *The subject could not remember what tooth was missing and it could 
not be verified with her orthodontist as he had retired and her records/treatment plan were not 
kept. 
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Figure 6.  Full mouth radiograph series of subject 02B.  Showing nine congenitally missing 
teeth: both upper lateral incisors, upper left second premolar, both lower second premolars 
and all four 3rd molars.  The upper left first molar was extracted due to periodontal reasons. 
 
 
Figure 7.  Bitewing radiographs of subject 02E.  Showing four extracted third molars.  A 
panoramic radiograph or full mouth series was not able to be obtained for subject 02E.  
Based on the in-person clinical exam, all permanent teeth were present except third molars 
with no teeth congenitally missing.   
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Figure 8.  Panoramic radiograph of subject 03D.  Showing six congenitally missing teeth: 
both lower second premolars and all third molars. 
 
Candidate Variant Identification 
 Following the whole exome sequencing, variants categorized as pathogenic, likely 
pathogenic, and of unknown significance (ACMG Categories 1-3) were listed for the on-site 
subjects.  A total of 26 variants were shared only between the three affected subjects and 
missing in the unaffected subject.  Also, due to the chance that a variant may not be called 
during whole exome sequencing in one of the affected individuals, three separate lists of 
variants were created only comparing each affected subject to the unaffected subject.  One 
affected subject had a list of 206 variants, one had 203 variants and the remaining subject had 
436 variants.   
 An autosomal dominant pattern of inheritance was assumed for candidate gene 
analysis with affected individuals therefore most likely heterozygous for the mutant allele.  
The genes containing the variants identified from our whole exome sequencing data were 
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input into DOMINO resulting in a list of seven genes: 5 labeled “very likely dominant” 
(probability greater than or equal to 0.6 in table 2) and 2 labeled “either dominant or 
recessive” (probability between 0.4 and 0.6 in table 2).  CADD scores of the seven candidate 
variants within likely dominant genes as well as the amount of pLoF variants and pLI scores 
for each gene are recorded in table 2. 
 
TABLE 2 
CANDIDATE VARIANTS 
Gene Variant Sequence 
Change 
Amino 
Acid 
Change 
Minor 
Allele 
Frequency 
CADD 
Score 
DOMINO 
Probability 
gnomAD 
pLI 
AHCYL1 Non-
synonymous 
c.8A>G E3G 0.012% 32.0 0.989 0.99 
HOXB2 Non-
synonymous 
c.1009T>C 
 
S337P 0.146% 22.6 0.954 0 
VMP1 Three prime 
flank 
c.-26-20A>G  0.017% 12.5 0.939 0.96 
WNT5B Five prime 
intronic 
c.328+20G>A  0.013% 0.52 0.923 0.59 
JUP Five prime 
intronic 
c.*21C>A  0.282% 6.86 0.895 0 
RNF43 Non-
synonymous 
c.289G>A D97N 0.012% 26.4 0.434 0.73 
TPI1 HGMD 
disease mutant 
(DM) 
c.50T>G I17R 0.357% 25.1 0.408 0.03 
 
 
Candidate Variant Validation 
 In order to validate the segregation of the seven candidate variants, PCR – restriction 
enzyme validation studies were utilized.  Of the seven variants, it was determined through the 
use of the Mutalyzer (v2.0.32) software that only two variants either created or destroyed 
restriction enzyme sites and subsequently, could be utilized for restriction enzyme testing: 
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HOXB2 and JUP.  The software NEBcutter was then utilized to select the appropriate 
restriction enzyme for each variant or wild-type gene based on the number of cuts.  For 
HOXB2, Hpy188I was selected for the wild-type sequence, producing one cut, and BsoB1 for 
the mutant sequence, producing three cuts. For JUP, BceAI was selected for the wild-type 
sequence, producing two cuts, and AvaII for the mutant sequence, producing three cuts.  
Primers were selected utilizing Primer3 creating a roughly 600bp sequence for HOXB2 and a 
roughly 550bp sequence for JUP.   
The isolated DNA from the saliva samples of the off-site subjects and the blood 
samples of the on-site subjects was prepared for restriction enzyme testing utilizing the 
selected PCR primers and PCR amplification.   Following the restriction enzyme digest, gel 
electrophoresis was utilized to visualize any differences between the subjects in regards to 
the genes HOXB2 and JUP.  For HOXB2, the restriction enzyme Hpy188I, which cut the 
wild-type sequence, created a more easily distinguishable difference between wild-type and 
variant band patterns (fig. 9).  For JUP, the restriction enzyme AvaII, which cut the variant 
sequence, best revealed differences between the wild-type and variant band patterns (Figure 
10). 
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Figure 9.  HOXB2/Hpy188I Gel Electrophoresis.  A. Predicted band sizes/pattern for wild-
type and mutant alleles as well as for the possible genotypes.  Total length of the HOXB2 
PCR product is 667bp.  B. Cut positions of the restriction enzyme Hpy188I for the HOXB2 
PCR product.  C. An image of a gel post electrophoresis for the HOXB2/Hpy188I pairing in 
all subjects.  M = mutant band and W = wild-type band.  Due to considerably lower DNA 
concentration, 02B bands were difficult to visualize. 
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Figure 10.  JUP/AvaII Gel Electrophoresis.  A. Predicted band sizes/pattern for wild-type 
and mutant alleles as well as for the possible genotypes.  Total length of the JUP PCR 
product is 568bp.  B. Cut positions of the restriction enzyme AvaII for the JUP PCR product.  
C. An image of a gel post electrophoresis for the JUP/AvaII pairing in all subjects.  M = 
mutant band and W = wild-type band.   
 
In figure 9, both wild-type and mutant bands are visible for off-site subjects 03E, 
02A, and 02B while only a wild-type band is visible for on-site subject 02E.  As subject 02E 
is our control and does not exhibit the tooth agenesis phenotype, the subject would only 
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possess wild-type alleles, both of which would be cut, leading to the resultant lower 
molecular weight band only.  In on-site subjects, 03G, 03H, and 03D, their tooth agenesis 
phenotype would lead us to believe that there should be an uncut mutant band of higher 
molecular weight, which there is for all three subjects.  As all three subjects have a lower 
molecular weight band as well, this would signify that each subject is heterozygous, 
possessing both a variant and wild-type HOXB2 allele.  Since subjects 03E, 02A, and 02B’s 
band patterns and phenotypes segregate well with the known affected on-site subjects, 
HOXB2 cannot be ruled out as a candidate variant.  Unfortunately, due to a substantially 
lower DNA concentration, bands for subject 02B were difficult to visualize, but there does 
appear to be a mutant band at 550bp.   
In figure 10, a unique band is created from the restriction enzyme (AvaII) cutting the 
mutant allele that is roughly 250bp.  Another unique band is created that is ~100bp in the 
mutant allele, but it is obscured by a ~100bp band that is present for both wild-type and 
mutant alleles.  All affected on-site subjects (03G, 03H, and 03D) show this ~250bp band 
nicely.  As all three off-site subjects (03E, 02A, and 02B) possess the tooth agenesis 
phenotype, if JUP is the causal variant, they should both have this band as well.  Though 
concentration differences cause the bands to be fainter for the off-site subjects, it appears 
subject 03E does not have this band while both 02A and 02B does.  Subject 03E’s band 
pattern more closely resembles the control 02E’s.  Since the band pattern and phenotype does 
not segregate properly in subject 03E, JUP should likely be ruled out as a candidate variant.   
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CHAPTER 4 
DISCUSSION 
 Heterozygous variants in seven novel candidate genes were identified segregating 
with the tooth agenesis phenotype within this family.    Due to the abundance of benign 
heterozygous variants that can create a large amount of background noise, identifying 
monoallelic dominant mutations for Mendelian disorders can be rather difficult when 
compared to recessive conditions with biallelic inheritance.  This is likely why NGS-based 
studies are thought to be more efficient in identifying genes associated with recessive 
disorders than those associated with dominant disorders (Chong et al. 2015).  With these 
difficulties in mind, the machine learning tool DOMINO was utilized to assess the likelihood 
that a gene contains dominant changes (Quinodoz et al. 2017).  This reduced the potential 
candidate variants from an original twenty-six to the eventual seven, excluding the rest as 
likely recessive, which would not follow the inheritance pattern seen in this family.  
Candidate Variants 
AHCYL1 
 
 Adenosylhomocysteine hydrolase-like protein 1 (AHCYL1), also known as IP3 
receptor-binding protein released with IP3 (IRBIT), is an intracellular protein that is highly 
conserved among species, with 100% protein identity between human and mouse orthologs.  
AHCYL1 acts by binding to IP3R to release Ca
2+ from the endoplasmic reticulum resulting in 
the activation of multiple important downstream targets for developmental processes in 
higher organisms such as the fruit fly, zebrafish and mouse. For example, Ca2+ signaling 
mediated by IP3R was critical for proper ventral structures development in zebrafish embryos 
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(Cooper et al. 2006).  AHCYL1 (IRBIT) has also been shown to play a central role in 
stimulating epithelial fluid and HCO3
- secretion in both pancreatic and parotid secretory 
ducts.  Transepithelial fluid and HCO3
- secretion are crucial to epithelial survival (Yang et al. 
2009; Yang et al. 2011).  Although AHCYL1 has been associated with embryonic 
development in zebrafish and has a role within multiple epithelial tissues, AHCYL1’s role in 
tooth development has yet to be studied.   
 The AHCYL1 variant (c.8A>G) results in the replacement of a glutamic acid with 
glycine.  According to the CADD score (32.0), the variant is highly deleterious and would 
likely influence a phenotype.  The AHCYL1 gene is also extremely intolerant to loss-of-
function mutations (pLI of 0.99).  Despite the DOMINO, CADD, and pLI values all 
suggesting that the AHCYL1 variant is significant to a phenotype, the literature does not 
reveal any function related to tooth agenesis, nor a similar function to any known affecter 
genes.  Due to the lack of suitable restriction enzymes, AHCYL1 could not be verified as a 
candidate variant.  At this time, AHCYL1 is not considered a strong candidate variant based 
on the literature, but it cannot be eliminated as a candidate either. 
HOXB2 
 
 During the analysis of the candidate variants, the HOXB2 variant (c.1009T>C) 
emerged as a strong candidate as the gene was scored as very likely dominant by DOMINO 
(0.954).  The variant also appears to be highly deleterious (CADD score is 22.9) due to the 
resultant replacement of serine with proline at the position 337.  The gene did have a very 
weak pLI of 0.0 showing that HOXB2 is tolerant of loss-of-function mutations, but as the 
CADD score is high for this specific variant/mutation, the low pLI is not as worrisome.   
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Homeobox (HOX) genes encode a highly conserved family of transcription factors 
and act as master control genes during embryonic development.  HOX genes play a role in 
multiple cellular processes such as cell proliferation, differentiation and survival, which if 
dysregulated have been shown to lead to cancer formation (Abate-Shen 2002).  HOX genes 
also direct pattern formation in mammals by specifying regional identity within the embryo 
and controlling morphogenesis (Krumlauf 1994).  Each HOX gene’s position within a cluster 
correlates with their respective spatiotemporal expression throughout embryogenesis and 
importantly, within developing areas, HOX genes have defined domains that they are 
expressed in, but these domains overlap with one another.  For example, in the lung, several 
HOX genes, mainly from HOXA and HOXB clusters, are expressed along the respiratory tract 
with distinct distribution in the proximal-distal directions. Out of roughly ten HOX genes, 
only Hoxa5 mutant mice experienced respiratory tract defects leading to respiratory distress 
and death, which demonstrates the redundancy the overlapping expression of the HOX genes 
(Landry-Truchon et al. 2017; Clemenceau et al. 2018).   
  An earlier study found that tooth development was independent of a HOX axial 
patterning program, but the researchers only studied Hoxa2 expression (James et al. 2002).  
This decision to only look at one HOX gene may have neglected the redundancy seen in 
HOX genes’ expression as a few recent studies demonstrated HOX expression within the 
dental mesenchyme in the pharyngeal teeth of bony fishes and the expression of the HOX 
gene network in 15 deciduous tooth germs, mostly within the epithelial compartment of the 
tooth germ, between 18 and 24 weeks of embryonal development (D'Antò et al. 2006; Fraser 
et al. 2009).   
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Even more recently, a genome-wide association (GWA) study looking at primary 
tooth development during infancy of over 6000 individuals found a SNP (single nucleotide 
polymorphism) located between HOXB1 and HOXB2.  They further analyzed each SNP for 
an association with dental occlusion defects requiring orthodontic treatment by the age of 31 
years in 611 individuals, as tooth development influences dental occlusion.  They found that 
of the 10 SNPs tested, the SNP found within the HOXB gene cluster had a significant 
association with defects in occlusion caused by associated delayed tooth eruption and a lower 
number of teeth in infancy (Pillas et al. 2010). 
 Potentially, if HOXB2 is the actual causal gene, the redundancy seen by HOX genes 
may contribute to the seemingly sporadic expression of the tooth agenesis seen in the family 
as the amount and type of teeth missing vary rather widely.  HOXB2 was one of the two 
candidate variants that had a restriction enzyme site created or destroyed by the mutation.  
The restriction enzyme Hpy188I cuts the wild-type allele, so HOXB2 is further validated in 
figure 9 as there is an uncut allele (mutant allele) in all subjects that possess the tooth 
agenesis phenotype.  The only subject that had both alleles cut was the control, 02E, which 
should be expected as 02E should not have a mutant allele.  All in all, HOXB2 is a strong 
candidate variant based on the initial whole exome sequencing, variant analysis, restriction 
enzyme validation in the off-site subjects, and literature review.   
VMP1  
Vacuole membrane protein 1 (VMP1) is a multispanning membrane protein in the 
endoplasmic reticulum and was identified originally as a protein associated with pancreatitis 
(Dusetti et al. 2002).  VMP1 has been found to be essential for the formation of 
autophagosomes in mammals and controls ER contacts with other membranes, including 
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autophagic membranes, through the regulation of the Ca2+ pump sarcoplasmic reticulum 
calcium transport ATPase (SERCA) and of ER contact proteins VAPA and VAPB (Itakura 
and Mizushima 2010; Zhao et al. 2017; Zhao et al. 2018).  Additional to autophagy 
involvement, VMP1 is required for the secretion of soluble proteins that are transported via 
the ER-to-Golgi trafficking pathway, which is important for organelle homeostasis (Calvo-
Garrido et al. 2008; Morishita et al. 2019).  VMP1 was found to play key roles in the 
development of tumors, such as colorectal and hepatocellular tumors, through proliferation, 
autophagy, and metastasis processes (Guo et al. 2015). 
 Recently, it has been revealed that VMP1 is essential for the survival of zebrafish and 
mice during the larval and early embryonic periods, respectively.  In the Vmp1-deficient 
mice, lethality was seen around 7.5 and no later than 9.5 days postcoitum (dpc) and the 
Vmp1-deficient embryos at 7.5dpc were smaller than the wild-type embryos suggesting that 
VMP1 plays an important role during early embryonic development.  The researchers 
theorized the lethality was likely due to a deficiency in nutrient transfer, specifically of 
neutral lipids, from the mother to the embryo. The visceral endoderm is an extraembryonic 
layer that secretes lipoproteins to the epiblast between 5 and 10 dpc prior to the formation of 
the placenta.  This demonstrated that VMP1 likely also has a role in lipoprotein release from 
the ER membrane into the lumen to be secreted from structures such as liver, intestine, and 
visceral endoderm (Morishita et al. 2019).   Even though VMP1 plays a critical role in 
embryonic development, based on the proposed mechanism involved, VMP1 is likely not 
involved in odontogenesis but no research, to this point, has been done to confirm this. 
 The VMP1 variant (c.26-20A>G) does meet the requirements of a candidate variant: 
segregated correctly with the phenotype in the on-site subjects, likely inherited in an 
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autosomal dominant fashion (DOMINO probability of 0.939), and very intolerant of loss-of-
function mutations (pLI of 0.96).  VMP1 starts to look weaker as a candidate though, when 
the average CADD score (12.5) is taken into account and when the gene does not seem to 
have any related function to tooth agenesis.  There was again no restriction enzyme available 
for the variant, so it was not verified to be present in the off-site subjects.  Like AHCYL1, 
VMP1 cannot be eliminated as a candidate variant but is also not considered a strong 
candidate at this time. 
WNT5B 
 
 The WNT5B variant (c.328+20G>A) was found to have a 92.3% probability of being 
autosomal dominant, which placed it in the candidate variant pool.  WNT5B had a rather 
average pLI, which means that the gene is only moderately intolerant of loss-of-function 
mutations.  The weakest score for the variant was the CADD score, where it only achieved a 
score of 0.52, which may suggest that the mutation is not likely to be deleterious or 
phenotypically influential.  Even with the average pLI and weak CADD score, the WNT5B 
variant remains an interesting candidate due to what is found in the literature.   
Wnt signaling plays a key role in numerous processes during both embryonic 
development and adult homeostasis.  WNT5B is one member of at least 19 different Wnt 
proteins that have been identified in mammals.  Within the Wnt family of proteins there are 
two distinct classes: the canonical, β-catenin-dependent Wnts (such as WNT1, WNT2, 
WNT3, WNT3a and WNT7a) and the noncanonical Wnts (such as WNT4, WNT5a, WNT5b, 
WNT6 and WNT11).  The noncanonical Wnts are different in that they either act 
independently from or inhibit the canonical Wnt signaling pathway (Tamura and Nemoto 
2016).   
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Numerous Wnt signaling pathway components, such as ligands, transducers, 
receptors and transcription factors, have been found to be expressed within the dental 
mesenchyme and epithelium during human and mouse tooth development (Tamura and 
Nemoto 2016).  The indispensable role that the Wnt signaling family plays during tooth 
development has been demonstrated by the Wnt family’s and closely associated proteins’ 
association with tooth agenesis.  Within the Wnt family itself, WNT10A and WNT10B have 
already been identified as genes that are associated tooth agenesis (Plaisancie et al. 2013; 
Arzoo et al. 2014; Kantaputra et al. 2018).   The canonical class of Wnt proteins acts by 
binding to the Frizzled (Fz) family of receptors as well as the co-receptors lipoprotein 
receptor-related proteins (LRP) 4, 5 and 6 (Gordon and Nusse 2006).  LRP6 is a gene that is 
associated with tooth agenesis along with another, DKK1, which encodes the DKK protein 
that acts as an antagonist to LRP6 and ultimately Wnt signaling (Tamura and Nemoto 2016; 
Dinckan et al. 2018).   
Similarly structured WNT5A is strongly expressed in human dental papilla 
mesenchyme and alterations in its expression has been found to inhibit the proliferation and 
migration of human dental papilla cells ultimately leading to retardation of tooth 
development and altered tooth size (Peng et al. 2009; Lin et al. 2011).  Wnt5a has also been 
detected in dental follicle cells during mouse tooth development and acts as a negative 
regulator of canonical Wnt-mediated early dental follicle cell differentiation, so a feedback 
mechanism exists between the canonical and noncanonical Wnt signaling throughout tooth 
development (Sakisaka et al. 2015).   
WNT5B’s role in tooth development has not nearly been studied to the same extent as 
WNT5A’s role.  One study did find that Wnt5b was expressed within the papilla mesenchyme 
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of a mouse incisor at E16 and E18 but not at the same intensity as Wnt5a, which was also 
found to be expressed within the lingual cervical loop mesenchyme, odontoblasts, and 
follicle mesenchyme in addition to the papilla mesenchyme. No further discussion was made 
about Wnt5b throughout the study (Suomalainen and Thesleff 2010).  Another study 
evaluating Wnt signal transduction through knockout mouse models only listed Wnt5b 
knockout mice as viable with no detectable phenotype found (van Amerongen and Berns 
2006).  It should be pointed out, though, that there was no dental or oral phenotype 
mentioned for any Wnt gene or associated gene within this study.  This could mean that a 
tooth agenesis phenotype may have not been found or was simply not evaluated by the 
researchers. 
One last correlation between WNT5B and tooth development was found in the 
literature through WNT5B’s relationship with FGF3.  Fibroblast growth factor receptor 3 
(FGF3) expression within the dental mesenchyme is involved in the regulation of early tooth 
development (Bei and Maas 1998; Meyers et al. 1998; Aberg et al. 2004).  In a recent study, 
fgf3 expression was partially reduced in wnt5b mutants resulting in jaw cartilage defects, 
which were rescued with the reintroduction of fgf3 mRNA.  It does need to be noted that 
there was no mention of a tooth agenesis phenotype being found within the wnt5b mutant 
mouse model, but again, developing tooth buds in the embryos may have not been evaluated 
by the researchers in this study (Wu et al. 2015).  
There was no suitable restriction enzyme found at the variant site that would have 
allowed for further validation in the off-site subjects, but the literature seems to suggest that 
WNT5B may, in fact, play a role in odontogenesis and be the causal variant behind this 
family’s phenotype.   
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JUP 
JUP encodes the protein plakoglobin, a member of the catenin protein family, found 
primarily in cells of the skin and heart.  The protein is a part of two specialized structures, 
adherens junctions and desmosomes, both of which help attach neighboring cells together to 
provide stability to tissues (Whittock et al. 2000).  Loss-of-function mutation of JUP has 
been found in patients experiencing Naxos disease, which is characterized by palmoplantar 
keratoderma, curly wooly hair and serious cardiac disorders, such as arrythmogenic right 
ventricular dysplasia (Whittock et al. 2000; Li et al. 2012). 
 Interactions between the dental epithelium and mesenchyme have a critical role in 
morphogenesis.  During odontogenesis, there is a stark histomorphogenesis from a relatively 
homogeneous dental bud giving rise to a more complex enamel organ with an inner and outer 
dental epithelium, stellate reticulum, stratum intermedium and terminal differentiation of 
ameloblasts.  Cell-to-cell adhesions facilitated by cadherins, transmembrane glycoproteins, 
are involved in this process.  E-cadherins complex with α-catenin, β-catenin and plakoglobin 
(γ-catenin) within epithelial cells to interact with microfilaments to form adherens junctions, 
which are important for cell growth and morphogenesis.  Immunolocalization of plakoglobin 
revealed that the antigen was present in epithelial cells from the early cap stage to the bell 
stage.  Throughout odontogenesis, expression of E-cadherin, α-catenin, β-catenin and 
plakoglobin varies both temporally and spatially throughout multiple tissues within the 
developing tooth (Fausser et al. 1998).  With the seemingly tight regulation of plakoglobin 
expression as early as the bud stage, it seems reasonable to suspect that a variant in JUP 
could lead to dysregulation of plakoglobin and result in an altered tooth development or 
potentially arrest tooth development. 
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Another notable interaction of JUP/plakoglobin occurs with lymphoid enhancer 
factor-1 (LEF1) to regulate cadherin function (Fausser et al. 1998).  LEF1, through its 
interactions with β-catenin and Wnt signaling, plays a role in early tooth development 
(Kratochwil et al. 2002; Chen et al. 2009).  It also affects the critical epithelial-mesenchymal 
interaction through its direct regulation of FGF4 with its downstream effects on FGF3 
expression in the dental mesenchyme and SHH expression in the dental epithelium (Sasaki et 
al. 2005).  Further, an analysis of Lef −/− embryos showed an absence of LEF1 leads to a 
complete lack of tooth development (Kratochwil et al. 2002).  Thus JUP may affect tooth 
development indirectly through LEF1 interactions.  
According to DOMINO, the JUP variant (c.*21C>A) is very likely autosomal 
dominant but to the lower end of that category at 0.83.  As for the rest of the variant analysis, 
JUP scores very weakly, having a CADD score of 6.86 and pLI of 0.  JUP is also one of the 
two candidate variants that had a suitable restriction enzyme.  AvaII is a restriction enzyme 
that cuts the wild-type allele only twice and the mutant allele three times creating a unique 
~250bp band if the subject possessed a mutant allele.  Off-site subject 03E was confirmed to 
have the tooth agenesis phenotype, so it would be expected that she would also have the JUP 
mutant allele if the JUP variant is truly the causal variant.  Yet, in figure 10, it appears that 
there is no band at roughly 250bp for subject 03E just like in the control on-site subject 02E.  
So, even though JUP looked promising as a candidate variant based on the literature, these 
findings suggest it is not the causal variant.   
TPI1 
 TPI1 encodes the enzyme triosephosphate isomerase 1, involved in the crucial 
energy-producing process of glycolysis by converting dihydroxyacetone phosphate (DHAP) 
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into glyceraldehyde 3-phosphate (GAP).  In the autosomal recessive disease TPI deficiency, 
glycolysis is impaired and there is a resultant decreased supply of energy within cells.  This 
reduction can lead to hemolytic anemia and neurological symptoms such as severe distal 
weakness (Roland et al. 2019).  It has been observed though, that TPI mutations can produce 
a spectrum of clinical symptoms in individuals as two identical twins with the same TPI 
genotype were shown to have differing health outcomes.  Differing degrees of penetrance 
and expressivity may explain this variance (Hollán et al. 1993).  Throughout the literature, 
there are no studies evaluating TPI1 and tooth development and it does not appear that TPI1 
has any function that is similar to known genes with odontogenic roles. 
 This specific TPI1 variant has previously been reported as causing hemolytic anemia 
and can be found in the OMIM database (#615512).  Like RNF43, TPI1 is another variant 
that barely made the cut as DOMINO labeled it as “either dominant or recessive.”  The 
variant also had a strong CADD score of 25.1 but very weak pLI of 0.03.  The TPI1 variant 
did not create or destroy a restriction enzyme site, so it could not be further validated in the 
off-site subjects.  Overall, TPI1 is not likely to be the causal variant based on the literature 
showing unrelated functions and the fact that it was previously reported with an unconnected 
phenotype.   
RNF43 
 With a DOMINO probability of 0.434, RNF43 (c.289G>A) was a candidate variant 
that barely made the cut as the software labeled it as “either dominant or recessive.”  
Nevertheless, the CADD score of 26.4 suggests that the mutation is not a benign one and 
likely influential on a phenotype.  A pLI of 0.73 also points to a gene that is not tolerant to 
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loss-of-function variations.  The mutation led to an amino acid change at position 97 from an 
aspartic acid to an asparagine. 
RNF43 is a member of the RING finger E3 ubiquitin ligase family.  It functions as a 
tumor suppressor by exerting a negative feedback mechanism in the Wnt/β-catenin signaling 
pathway through ubiquitinating the frizzled family of Wnt receptors for degradation and 
consequent downregulation of Wnt signaling (Tu et al. 2019).  RNF43 was originally 
identified as an oncoprotein with upregulated expression in colon cancer and RNF43 
mutations have since been associated with gastric, pancreatic, and endometrial 
adenocarcinomas, pancreatic cystic lesions, and ovarian mucinous tumors.  Loss-of-function 
mutations can lead to permanent activation of the Wnt/β-catenin signaling pathway in cancer 
cells (Serra and Chetty 2018).   
 Members of the R-spondin family have been identified as activators of the Wnt 
signaling pathway.  Lgr4, Lgr5, and Lgr6 are receptors for R-spondins and the resulting R-
spondin/Lgr signaling has been demonstrated to be involved in the development of murine 
teeth (Kawasaki et al. 2014).  A study in 2014 revealed that Lgr4, Lgr5, and Lgr6 efficiently 
recruited R-spondin ligands and helped guide them into position for an interaction with 
RNF43 resulting in RNF43’s inactivation in intestinal epithelial crypt stem cells.  This 
Lgr/R-spondin complex neutralizing RNF43 would allow for a subsequent enhancement of 
Wnt signaling.  The control of the adult stem cells was shown to be through a delicate 
interplay between potent Wnt agonists, antagonists, and anti-antagonists (de Lau et al. 2014).  
DKK1, also a Wnt signaling inhibitor, is known to be associated with tooth agenesis when 
overexpressed (Dinckan et al. 2018).  
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Figure 11. 3D rendering of the RSPO1-LGR5-RNF43 complex.  The crystal structure of the 
RSPO1-LGR5-RNF43 complex was published in a study by Chen et al. 2013.  A. Miniature 
view showing the β-hairpin of RSPO1 insertion into the RNF43 groove.  B. and C. Magnified 
views depicting the hydrogen bonding and salt bridge networks mediated between the R66 
and Q71 residues of RSPO1 and Q84, H86, and D97 residues of RNF43. 
 
An even more interesting observation was found in a study by Chen et al. 2013, 
which took a deeper dive into the protein structures of the RSPO1-LGR5-RNF43 complex.  
We can see in their figure (fig. 11), that a network of hydrophilic interactions plays an 
important role in the recognition and micromolar affinity of the β-hairpin protrusion from 
RSPO1 and the shallow binding groove of RNF43.  One key residue is the asparagine at 
position 97, which happens to be the same residue altered in our family with tooth agenesis 
(2013). 
44 
 
 
Figure 12. Rnf43 expression in developing murine molars.  A figure in a thesis from Ainetdin 
2019 showing the expression of Rnf43 RNA (bright red staining) in developing murine 
molars at the placode (E12.5), bud (E13.5), and cap stages (E14.5).  Dashed lines were added 
to delineate the border of the dental epithelium and mesenchyme (2019). 
 
Currently, there has not been a study done evaluating if there is similar interplay 
between RNF43, R-spondins and Lgr receptors to direct Wnt signaling during tooth 
development, but there is another study that theorized about this connection to tooth 
development (Ainetdin 2019).  A thesis conducted in Finland evaluated Rnf43 expression at 
the various stages of tooth development in murine teeth and found that Rnf43 RNA was 
expressed within the tooth epithelium as early as the placode stage, the earliest stage they 
evaluated (fig. 12).  The most significant detail of the thesis was through a personal 
communication with Dr. Pekka Nieminen, it was revealed that three families, in a larger 
study of 151 families with tooth agenesis, had heterozygous mutations in RNF43.  These 
three families were not included in the original published article (Arte et al. 2013).  Two of 
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the families had a lysine replacing an asparagine at position 179 but one family had an 
asparagine replacing an aspartic acid at position 97, identical to the mutation in our family.  
 
 
Figure 13. 3D modeling of RSPO1-RNF43 and RSPO2-ZNRF3 interactions.  A. 3D 
modeling of RSPO1 and RNF43 proteins demonstrating the difference in interactions 
between aspartic acid’s and asparagine’s side chain with the residues of RSPO1.  B. 3D 
modeling of RSPO2 and ZNRF3 drawing attention to the interactions of the D97 and N179 
residues with RSPO2 protein.  3D models created using MacPyMOL v.1.8.6.0. 
 
With this in mind, a 3D modeling program (MacPyMOL, version 1.8.6.013) was 
utilized to analyze how a change in the residue at position 97 from an aspartic acid to an 
asparagine may alter RNF43’s interactions with RSPO1, shown in figure 13A.  It appears 
that the change to the neutral polar side chain of asparagine leads to a weaker bond to RSPO1 
compared to the acidic polar side chain of aspartic acid.  To visualize the N179 residue’s 
interactions with the R-spondin protein structure, the other residue altered that was found in a 
family with tooth agenesis, ZNRF3 was utilized, which is highly homologous to RNF43.  We 
                                                 
13 PyMOL Molecular Graphics System, Schrödinger, 120 W 45th Street, 17th Floor, New York City, NY 10036 
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can see that the N179 residue has very similar interactions with the R-spondin protein just on 
the opposite side of D97.   
 
Summary  
 
 Our initial pool of candidate variants following the sequencing of the on-site subjects 
was 26 variants, further narrowed down to 7 by analyzing the likelihood that each gene was 
inherited in an autosomal dominant fashion.  Even though JUP appeared to be a promising 
candidate based on the analytics and literature, the JUP mutant variant was not present in the 
affected off-site subject 03E (Figure 10).  JUP was consequently eliminated from the 
candidate variant pool leaving only six: AHCYL1, HOXB2, VMP1, WNT5B, RNF43, and 
TPI1.   
Based on the literature review, WNT5B, HOXB2, and RNF43 are considered to be the 
most biologically plausible candidate genes based on their biological roles and/or interactions 
with known odontogenic effectors.   WNT5B expression has been found within the dental 
papilla mesenchyme and a potentially significant relationship with FGF3 was discovered, 
which is also expressed in the dental mesenchyme during early tooth development 
(Suomalainen and Thesleff 2010; Wu et al. 2015).  HOXB2 is a member of the highly 
conserved Homeobox family of transcription factors.  A gene network that appears to be 
active within human tooth germs during embryonic development, mostly within the epithelial 
tooth germ compartment (D'Antò et al. 2006).  RNF43 expression was found within the 
dental epithelium at the placode stage in murine teeth and acts as a negative feedback 
regulator of the Wnt signaling pathway (Ainetdin 2019; Tu et al. 2019). 
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MSX1 and PAX9, two major genes involved with tooth agenesis, are both key 
regulators in the critical epithelial-mesenchymal interactions during early odontogenesis, 
demonstrating the importance of tight control over these interactions  (Peters et al. 1998a; 
Jernvall and Thesleff 2000; Yin and Bian 2015).  RNF43, WNT5B, HOXB2, and the 
associated genes mentioned have all been shown to be expressed within these tissues during 
the early stages of tooth development.  Similarly to MSX1 and PAX9, alterations in their 
expression may potentially lead to dysregulation of the epithelial-mesenchymal interactions 
required for proper tooth development. 
The RNF43 variant stands out as the likely causal variant due to the significant effect 
caused by the mutation leading to an amino acid change altering an influential interaction site 
between RNF43 and R-spondin proteins (Chen et al. 2013).  This notion was strengthened 
further with the finding that three families with tooth agenesis have mutations in RNF43, one 
family having the same amino acid change (D97N) as our family, and all three mutations 
have been shown to affect the same interaction site between the RNF43 binding groove and 
R-spondin β-hairpin protrusion (Chen et al. 2013; Ainetdin 2019).  This demonstrates the 
importance of the LGR-RSPO complex’s regulation of RNF43 and consequently, RNF43’s 
regulation of Wnt signaling in the early stages of tooth development.  Wnt signaling’s role in 
tooth development is well studied and its association with tooth agenesis has already been 
reported with WNT10A and WNT10B (Arzoo et al. 2014; Kantaputra et al. 2018).   
Study Limitations 
 While I attempted to recruit all thirteen family members for this study, only seven 
members were able to be enrolled.  A larger amount of family members sequenced would 
have been desirable to reduce the background noise created by the abundant benign 
48 
 
heterozygous variants that could have segregated along with the actual causal variant(s) 
(Chong et al. 2015).   
 Of the initial seven candidate variants, only two variants were found to either create 
or destroy a restriction enzyme site, which allowed for further analysis in the off-site 
subjects.  This means that only two of the variants were truly studied in all seven of the 
recruited family members and the remaining five variants were only verified to segregate 
properly in the four on-site subjects through whole-exome sequencing.  Due to time 
constraints caused by the coronavirus pandemic, the remaining five variants were not 
evaluated within the three off-site subjects through other means, such as targeted DNA 
sequencing, as would have been preferred.  
 Differences in DNA concentrations between the DNA isolated from the on-site 
subjects’ blood samples and that of the off-site subjects’ saliva samples created difficulties in 
running gels that produced visible bands for the off-site subjects.  In an attempt to alleviate 
the issue, a greater volume was used during the gel runs for the off-site subjects than for the 
on-site subjects.  As seen in figure 9, the band density was much weaker for subject 02B, 
who had a significantly lower DNA concentration than even the other two off-site subjects, 
making it quite difficult to determine the band pattern.  The lower concentration of DNA 
isolated from the saliva samples could have been due to the protocol selected.  For possible 
future investigations, it may be beneficial to utilize a different protocol to see if any 
differences in DNA concentration are observed.   
 Another limitation was the inability to verify the number of congenitally missing 
teeth versus extracted teeth in subject 02A.  Since the subject had been treated 
orthodontically over 20 years ago, unfortunately, her orthodontist had retired and her 
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records/treatment plan were no longer available.  Without the records, it is difficult to rely on 
the memory of the patient.  As third molars are the most frequently missing teeth, if the 
subject ended up having all four premolars removed for orthodontic reasons instead of 
congenitally missing any, this could call into question her phenotype and could subsequently 
alter the interpretation of the data.  Although, based on the initially constructed pedigree, if 
subject 03A’s phenotype could be confirmed, the inheritance pattern would relieve some of 
the potential uncertainty in regards to subject 02A’s phenotypic presentation.    
Clinical Implications 
 Although the clinical implications of revealing candidate variants for tooth agenesis 
are limited currently, the knowledge gained from genetic studies such as this one could lead 
to further understanding of the complex interplay of various genes throughout the 
development of teeth.  With the discovery of the CRISPR-Cas9, an RNA-guided genome 
editing tool, the potential for targeted gene therapy has become a real possibility (Xiao-Jie et 
al. 2015).   Before it could ever be used clinically to benefit patients, especially for a 
condition as often benign as tooth agenesis, significant developments are still required to 
overcome multiple challenges.  Also, as scientific developments continue to be made in the 
area of lab grown organs, there could be a future where dental implants and bridges, used for 
missing teeth, could be replaced with an actual tooth (Wörsdörfer et al. 2019; Sorrentino et 
al. 2020). 
Future Investigations 
 Future studies could further evaluate the segregation of the five candidate variants 
that did not create or destroy a restriction enzyme site in the three off-site subjects through 
targeted sequencing.  Also, it would be ideal if the remaining family members could be 
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recruited, which would further verify the initially drafted pedigree and alleviate any 
questions about phenotypic presentation of subject 02A.  Both steps could potentially narrow 
down the candidate variant list further. 
 Further investigation into the functional consequences of the RNF43 mutation would 
be beneficial, possibly through the creation of a knock-out or knock-in mouse model.  
RNF43 expression has already been found in the dental epithelium throughout the early 
stages of tooth development, but the consequences of the mutation have not (Ainetdin 2019).  
Another question that arises is if the phenotype in this family is inherited through monogenic 
or oligogenic inheritance.  Multilocus variation models and oligogenic inheritance have 
recently been proposed for multiple Mendelian disorders (Posey et al. 2017).  Oligogenic 
inheritance has already been suggested for the tooth agenesis phenotype as a family was 
identified to have novel heterozygous, potentially splicing mutations in DKK1 and COL17A1 
as well as a heterozygous missense variant in LAMA3, all segregating with tooth agenesis 
within the family (Dinckan et al. 2018).  Before any strong statement could be made 
regarding oligogenic inheritance playing a role in the tooth agenesis phenotype seen in this 
study’s family, further analysis of the remaining un-recruited family members and a deeper 
dive into the genetics of the off-site subjects would be necessary.  
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CHAPTER 5 
CONCLUSIONS 
1. There were six common single gene mutations found only in affected family 
members.  Based on the literature review and the utilization of analytic software, the 
causal variant is likely RNF43.   
2. Of the six candidate genes, RNF43, HOXB2, and WNT5B were shown to be expressed 
during the early stages of tooth formation in the literature, which further supports the 
potentially impactful role that the RNF43 mutation could have on the tooth agenesis 
phenotype.    
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